Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Operating Income: 2019-2024

Historic Operating Income for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to -$34.5 million.

  • Biodesix's Operating Income rose 17.93% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.6 million, marking a year-over-year increase of 6.23%. This contributed to the annual value of -$34.5 million for FY2024, which is 16.55% up from last year.
  • Latest data reveals that Biodesix reported Operating Income of -$34.5 million as of FY2024, which was up 16.55% from -$41.3 million recorded in FY2023.
  • In the past 5 years, Biodesix's Operating Income ranged from a high of -$22.9 million in FY2020 and a low of -$50.6 million during FY2022.
  • Moreover, its 3-year median value for Operating Income was -$41.3 million (2023), whereas its average is -$42.1 million.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 78.51% in 2021, then grew by 18.28% in 2023.
  • Over the past 5 years, Biodesix's Operating Income (Yearly) stood at -$22.9 million in 2020, then tumbled by 78.51% to -$40.9 million in 2021, then declined by 23.56% to -$50.6 million in 2022, then climbed by 18.28% to -$41.3 million in 2023, then rose by 16.55% to -$34.5 million in 2024.